Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 535

1.

Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.

Malaguarnera M, Gargante MP, Cristaldi E, Vacante M, Risino C, Cammalleri L, Pennisi G, Rampello L.

Dig Dis Sci. 2008 Nov;53(11):3018-25. doi: 10.1007/s10620-008-0238-6. Epub 2008 Mar 21.

PMID:
18357530
2.

Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.

Malaguarnera M, Vacante M, Motta M, Giordano M, Malaguarnera G, Bella R, Nunnari G, Rampello L, Pennisi G.

Metab Brain Dis. 2011 Dec;26(4):281-9. doi: 10.1007/s11011-011-9260-z. Epub 2011 Aug 26.

PMID:
21870121
3.

Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.

Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Görtelmeyer R, Hendricks R, Krüger B, Kuklinski B, Meister H, Otto HJ, Rink C, Rösch W, Stauch S.

Hepatology. 1997 Jun;25(6):1351-60.

PMID:
9185752
4.

Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy.

Malaguarnera M, Bella R, Vacante M, Giordano M, Malaguarnera G, Gargante MP, Motta M, Mistretta A, Rampello L, Pennisi G.

Scand J Gastroenterol. 2011 Jun;46(6):750-9. doi: 10.3109/00365521.2011.565067. Epub 2011 Mar 28.

PMID:
21443422
5.

Effects of L-acetylcarnitine on cirrhotic patients with hepatic coma: randomized double-blind, placebo-controlled trial.

Malaguarnera M, Pistone G, Astuto M, Vecchio I, Raffaele R, Lo Giudice E, Rampello L.

Dig Dis Sci. 2006 Dec;51(12):2242-7. Epub 2006 Nov 1.

PMID:
17080254
6.

Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study.

Stauch S, Kircheis G, Adler G, Beckh K, Ditschuneit H, Görtelmeyer R, Hendricks R, Heuser A, Karoff C, Malfertheiner P, Mayer D, Rösch W, Steffens J.

J Hepatol. 1998 May;28(5):856-64.

PMID:
9625322
7.

Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA treatment in hepatic coma: a randomized and controlled double blind study.

Malaguarnera M, Risino C, Cammalleri L, Malaguarnera L, Astuto M, Vecchio I, Rampello L.

Eur J Gastroenterol Hepatol. 2009 Jul;21(7):762-70. doi: 10.1097/MEG.0b013e328309c791.

PMID:
19357525
8.

Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.

Malaguarnera M, Gargante MP, Cristaldi E, Colonna V, Messano M, Koverech A, Neri S, Vacante M, Cammalleri L, Motta M.

Arch Gerontol Geriatr. 2008 Mar-Apr;46(2):181-90. Epub 2007 Jul 20.

PMID:
17658628
9.

An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy.

Sharma P, Sharma BC, Puri V, Sarin SK.

Eur J Gastroenterol Hepatol. 2008 Jun;20(6):506-11. doi: 10.1097/MEG.0b013e3282f3e6f5.

PMID:
18467909
10.

Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.

Malaguarnera M, Vacante M, Giordano M, Pennisi G, Bella R, Rampello L, Malaguarnera M, Li Volti G, Galvano F.

Am J Clin Nutr. 2011 Apr;93(4):799-808. doi: 10.3945/ajcn.110.007393. Epub 2011 Feb 10.

11.

Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.

Malaguarnera M, Greco F, Barone G, Gargante MP, Malaguarnera M, Toscano MA.

Dig Dis Sci. 2007 Nov;52(11):3259-65. Epub 2007 Mar 28.

PMID:
17393330
12.

A double-blind, randomized, placebo-controlled trial of intravenous L-ornithine-L-aspartate on postural control in patients with cirrhosis.

Schmid M, Peck-Radosavljevic M, König F, Mittermaier C, Gangl A, Ferenci P.

Liver Int. 2010 Apr;30(4):574-82. doi: 10.1111/j.1478-3231.2010.02213.x.

PMID:
20456040
13.

Minimal hepatic encephalopathy in patients with decompensated liver cirrhosis.

Marić D, Klasnja B, Filipović D, Brkić S, Ruzić M, Bugarski V.

Acta Clin Croat. 2011 Sep;50(3):375-80.

PMID:
22384773
14.

Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.

Sharma P, Sharma BC, Sarin SK.

Liver Int. 2009 Oct;29(9):1365-71. doi: 10.1111/j.1478-3231.2009.02067.x. Epub 2009 Jun 23.

PMID:
19555401
15.

Screening for minimal hepatic encephalopathy in asymptomatic drivers with liver cirrhosis.

Gad YZ, Zaher AA, Moussa NH, El-desoky AE, Al-Adarosy HA.

Arab J Gastroenterol. 2011 Jun;12(2):58-61. doi: 10.1016/j.ajg.2011.04.002. Epub 2011 Jun 12.

PMID:
21684474
16.

A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.

Mittal VV, Sharma BC, Sharma P, Sarin SK.

Eur J Gastroenterol Hepatol. 2011 Aug;23(8):725-32. doi: 10.1097/MEG.0b013e32834696f5.

PMID:
21646910
17.

Acetyl-L-carnitine in the management of pain during methadone withdrawal syndrome.

Janiri L, Martinotti G, Tonioni F, Ghelardini C, Nicolai R, Galeotti N, Mosconi L, Calvani M, Bartolini A, Iannoni E.

Clin Neuropharmacol. 2009 Jan-Feb;32(1):35-40. doi: 10.1097/WNF.0B013E31815DD465.

PMID:
18978503
18.

Minimal hepatic encephalopathy and extrapyramidal signs in patients with cirrhosis.

Jover R, Compañy L, Gutiérrez A, Zapater P, Pérez-Serra J, Girona E, Aparicio JR, Pérez-Mateo M.

Am J Gastroenterol. 2003 Jul;98(7):1599-604.

PMID:
12873585
19.

Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy.

Malaguarnera M, Gargante MP, Malaguarnera G, Salmeri M, Mastrojeni S, Rampello L, Pennisi G, Li Volti G, Galvano F.

Eur J Gastroenterol Hepatol. 2010 Feb;22(2):199-206. doi: 10.1097/MEG.0b013e328330a8d3.

PMID:
19730107
20.

L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy.

Ahmad I, Khan AA, Alam A, Dilshad A, Butt AK, Shafqat F, Malik K, Sarwar S.

J Coll Physicians Surg Pak. 2008 Nov;18(11):684-7. doi: 11.2008/JCPSP.684687.

PMID:
18983791

Supplemental Content

Support Center